US4078046A
(en)
*
|
1975-03-10 |
1978-03-07 |
University Of Southern California |
Process for the catalytic oxidation of carbon monoxide with sulfur dioxide and water
|
DE2556561C2
(de)
*
|
1975-12-16 |
1983-04-14 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur Herstellung von porösen Tabletten
|
GB1548022A
(en)
*
|
1976-10-06 |
1979-07-04 |
Wyeth John & Brother Ltd |
Pharmaceutial dosage forms
|
IE45770B1
(en)
*
|
1976-10-06 |
1982-11-17 |
Wyeth John & Brother Ltd |
Pharmaceutical dosage forms
|
US4568547A
(en)
*
|
1979-08-30 |
1986-02-04 |
Herschler R J |
Solid pharmaceutical compositions comprising MSM and their production
|
US4883182A
(en)
*
|
1985-05-31 |
1989-11-28 |
Hughes Raymond J |
Tamper evident capsule and insert device
|
GB8624628D0
(en)
*
|
1986-10-14 |
1986-11-19 |
Scras |
Soluble/splitable tablets
|
CA2124686C
(en)
*
|
1991-12-20 |
1998-06-16 |
Julian B. Lo |
Porous shaped delivery devices and method of producing thereof
|
CA2117351C
(en)
*
|
1992-01-13 |
1998-03-03 |
Julian Belknap Lo |
Preparation of tablets of increased strength
|
HUT75616A
(en)
*
|
1992-03-17 |
1997-05-28 |
Pfizer |
Method for prooucing porous delivery devices
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
AU3570495A
(en)
|
1994-09-22 |
1996-04-09 |
Quadrant Holdings Cambridge Limited |
Compositions for use in rehydration and nutrition during athletic exercise and methods of making same
|
US6964771B1
(en)
|
1995-06-07 |
2005-11-15 |
Elan Drug Delivery Limited |
Method for stably incorporating substances within dry, foamed glass matrices
|
US5958455A
(en)
*
|
1996-02-09 |
1999-09-28 |
Quadrant Holdings Cambridge Ltd |
Oral solid dosage forms, methods of making same and compositions thereof
|
US5762961A
(en)
*
|
1996-02-09 |
1998-06-09 |
Quadrant Holdings Cambridge Ltd. |
Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof
|
US6632648B1
(en)
|
1996-05-14 |
2003-10-14 |
Elan Drug Delivery Limited |
Methods of terminal sterilization of fibrinogen
|
KR100481583B1
(ko)
*
|
1996-06-14 |
2005-07-12 |
교와 핫꼬 고교 가부시끼가이샤 |
구강내에서빠르게붕괴하는정제
|
CN1154479C
(zh)
*
|
1996-06-14 |
2004-06-23 |
协和发酵工业株式会社 |
口腔内快速崩解片剂
|
US8071128B2
(en)
*
|
1996-06-14 |
2011-12-06 |
Kyowa Hakko Kirin Co., Ltd. |
Intrabuccally rapidly disintegrating tablet and a production method of the tablets
|
CA2234245A1
(en)
|
1996-08-13 |
1998-02-19 |
Kyowa Hakko Kogyo Co. Ltd. |
Tablet of isotope-labeled urea
|
US6468782B1
(en)
|
1996-12-05 |
2002-10-22 |
Quadrant Healthcare (Uk) Limited |
Methods of preserving prokaryotic cells and compositions obtained thereby
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
GT199900061A
(es)
*
|
1998-05-15 |
2000-10-14 |
Pfizer |
Formulaciones farmaceuticas.
|
IL143071A0
(en)
|
1998-11-10 |
2002-04-21 |
Teva Pharma |
Dispersible compositions containing l-dopa ethyl ester
|
GB9908014D0
(en)
|
1999-04-08 |
1999-06-02 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6284270B1
(en)
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US20030185886A1
(en)
*
|
2000-05-26 |
2003-10-02 |
Hanmi Pharm. Co., Ltd. |
Process for the preparation of rapidly disintegrating tablet
|
US20020001617A1
(en)
*
|
2000-05-26 |
2002-01-03 |
Chang-Hyun Lee |
Rapidly disintegrating tablet and process for the manufacture thereof
|
GB0028709D0
(en)
*
|
2000-11-24 |
2001-01-10 |
S P A |
Process
|
US6544552B2
(en)
*
|
2001-01-11 |
2003-04-08 |
Particle And Coating Technologies, Inc. |
Method of producing porous tablets with improved dissolution properties
|
EP1365740A1
(en)
*
|
2001-02-08 |
2003-12-03 |
Pharmacia Corporation |
Rapid-onset medicament for the treatment of sexual dysfunction
|
US20040071772A1
(en)
*
|
2001-03-06 |
2004-04-15 |
Shoichi Narita |
Preparations quickly disintegrating in oral cavity
|
US6509040B1
(en)
|
2001-06-22 |
2003-01-21 |
R.P. Scherer Corporation |
Fast dispersing dosage forms essentially free of mammalian gelatin
|
US9358214B2
(en)
|
2001-10-04 |
2016-06-07 |
Adare Pharmaceuticals, Inc. |
Timed, sustained release systems for propranolol
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
ATE450252T1
(de)
*
|
2002-03-26 |
2009-12-15 |
Teva Pharma |
Arzneimittel-mikroteilchen
|
AU2003277296A1
(en)
*
|
2002-10-04 |
2004-05-04 |
Pharmacia Corporation |
Compositions and methods for treating sexual dysfunction
|
CA2501324A1
(en)
*
|
2002-10-30 |
2004-05-21 |
Pharmacia Corporation |
Oral extended release tablets and methods of making and using the same
|
US8367111B2
(en)
*
|
2002-12-31 |
2013-02-05 |
Aptalis Pharmatech, Inc. |
Extended release dosage forms of propranolol hydrochloride
|
US7749533B2
(en)
*
|
2003-05-07 |
2010-07-06 |
Akina, Inc. |
Highly plastic granules for making fast melting tablets
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US8747895B2
(en)
*
|
2004-09-13 |
2014-06-10 |
Aptalis Pharmatech, Inc. |
Orally disintegrating tablets of atomoxetine
|
US9884014B2
(en)
*
|
2004-10-12 |
2018-02-06 |
Adare Pharmaceuticals, Inc. |
Taste-masked pharmaceutical compositions
|
MX2007004741A
(es)
|
2004-10-21 |
2007-09-07 |
Eurand Pharmaceuticals Ltd |
Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
|
PT1804764E
(pt)
*
|
2004-10-28 |
2008-09-11 |
Pantec Ag |
Uma forma de dosagem sólida de desintegração rápida e altamente porosa e o seu modo de fabricação compreendendo a preparação de um pó e um passo de liofilização
|
US20060105038A1
(en)
*
|
2004-11-12 |
2006-05-18 |
Eurand Pharmaceuticals Limited |
Taste-masked pharmaceutical compositions prepared by coacervation
|
US9161918B2
(en)
|
2005-05-02 |
2015-10-20 |
Adare Pharmaceuticals, Inc. |
Timed, pulsatile release systems
|
GB0516604D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sandoz Ag |
Rapidly dispersing/disintegrating compositions
|
US20090068262A1
(en)
*
|
2007-04-04 |
2009-03-12 |
Ilan Zalit |
Rapid dissolution of combination products
|
WO2009002084A2
(en)
*
|
2007-06-27 |
2008-12-31 |
Hanmi Pharm. Co., Ltd. |
Method for preparing rapidly disintegrating formulation for oral administration and apparatus for preparing and packing the same
|
US20090060983A1
(en)
*
|
2007-08-30 |
2009-03-05 |
Bunick Frank J |
Method And Composition For Making An Orally Disintegrating Dosage Form
|
RU2482839C2
(ru)
*
|
2007-10-31 |
2013-05-27 |
МакНЕЙЛС-ППС, ИНК. |
Распадающаяся в полости рта лекарственная форма
|
US20120100212A1
(en)
*
|
2009-07-06 |
2012-04-26 |
Kyorin Pharmaceutical, Co., Ltd. |
Tablet having hollow structure
|
US20110070286A1
(en)
*
|
2009-09-24 |
2011-03-24 |
Andreas Hugerth |
Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
|
US8343533B2
(en)
|
2009-09-24 |
2013-01-01 |
Mcneil-Ppc, Inc. |
Manufacture of lozenge product with radiofrequency
|
US20110318411A1
(en)
|
2010-06-24 |
2011-12-29 |
Luber Joseph R |
Multi-layered orally disintegrating tablet and the manufacture thereof
|
US8313768B2
(en)
|
2009-09-24 |
2012-11-20 |
Mcneil-Ppc, Inc. |
Manufacture of tablet having immediate release region and sustained release region
|
TWI471146B
(zh)
|
2009-12-02 |
2015-02-01 |
Aptalis Pharma Ltd |
菲索特芬那定(fexofenadine)微膠囊及包含其之組合物
|
US20110212171A1
(en)
*
|
2010-01-08 |
2011-09-01 |
Eurand, Inc. |
Taste masked topiramate composition and an orally disintegrating tablet comprising the same
|
US9445971B2
(en)
|
2012-05-01 |
2016-09-20 |
Johnson & Johnson Consumer Inc. |
Method of manufacturing solid dosage form
|
US9511028B2
(en)
|
2012-05-01 |
2016-12-06 |
Johnson & Johnson Consumer Inc. |
Orally disintegrating tablet
|
US9233491B2
(en)
|
2012-05-01 |
2016-01-12 |
Johnson & Johnson Consumer Inc. |
Machine for production of solid dosage forms
|
MX368159B
(es)
|
2014-01-10 |
2019-09-20 |
Johnson & Johnson Consumer Inc |
Proceso para elaborar tabletas con el uso de radiofrecuencia y partículas disipativas revestidas.
|
WO2017182589A1
(en)
|
2016-04-21 |
2017-10-26 |
Astrazeneca Ab |
Orally disintegrating tablets
|
US10493026B2
(en)
|
2017-03-20 |
2019-12-03 |
Johnson & Johnson Consumer Inc. |
Process for making tablet using radiofrequency and lossy coated particles
|